Boehringer Ingelheim becomes an official partner to CatCareforLife

  • The CatCareforLife program is a new worldwide initiative set up by the International Society of Feline Medicine
  • It aims to encourage cat owners to work with their veterinary clinics to maintain cats in the peak of health through all their life stages
  • Boehringer Ingelheim is committed to further improving the health and well-being of cats and helping educate veterinarians and cat owners

Ingelheim, Germany, 7 November 2018 – Boehringer Ingelheim is proud to announce its new partnership with the CatCareforLife  program. The program was set up in April 2018 by the International Society of Feline Medicine (ISFM), the veterinary division of the UK-based charity International Cat Care (ICC). Both Boehringer Ingelheim and ICC share a common commitment in providing support for veterinarians and cat owners alike to ensure cats enjoy longer, happier and healthier lives, through an effective and tailored preventive healthcare approach.
The CatCareforLife program sits alongside the Cat Friendly Clinic program which offers internationally-recognized standards to help reduce stress of cats during veterinary visits. It is a lifelong partnership of care between cat owners and veterinary clinics through all life stages, from kittens through to old age.
The program provides a full set of recommendations established by international experts and organizations to support, educate, and raise the level of care for feline patients.
Three levels in prevention should be considered for a comprehensive approach:

  • Primary prevention consists in avoiding the development of diseases; this could be achieved thanks to vaccination or antiparasitic treatments.
  • Secondary prevention regards the early detection of a disease and how its progression could be delayed and/or stopped.
  • Finally, tertiary prevention concerns the reduction of the impact of an established disease, for instance by managing its complications.

Secondary and tertiary measures become more critical as the cat ages and as diseases become more prevalent. Both the cat owner and the veterinary team need to be aware of the importance of such preventive program, especially as cats often do not show signs of disease. Cats are masters for masking symptoms, thereby regular vet examinations are all the more important for this species.
Shawn Hooker, Head of Strategic Business Unit Pet Vet at Boehringer Ingelheim, shared: “We are passionate about the lifelong well-being of cats, and are proud to support the CatCareforLife program. We share a common goal with ISFM to ensure that all cats receive optimal veterinary care throughout their lives, with regular, stress-free health checks and preventive healthcare, and with early diagnosis and treatment of disease. This is the best way of protecting the health of the cat and preserving the human-animal bond.”
Through this partnership, Boehringer Ingelheim will actively promote this world-wide initiative and develop practical and informational tools and services to enhance veterinarians’ and cat owners’ knowledge.
Boehringer Ingelheim
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.